Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 557

1.

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.

Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY.

N Engl J Med. 2004 Jan 29;350(5):459-68.

2.

Strontium ranelate: a new paradigm in the treatment of osteoporosis.

Reginster JY, Deroisy R, Jupsin I.

Drugs Today (Barc). 2003 Feb;39(2):89-101. Review.

PMID:
12698204
3.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.

Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY.

Osteoporos Int. 2009 Oct;20(10):1663-73. doi: 10.1007/s00198-008-0825-6. Epub 2009 Jan 20.

4.

Strontium ranelate in osteoporosis.

Reginster JY.

Curr Pharm Des. 2002;8(21):1907-16. Review.

PMID:
12171530
5.

Strontium ranelate: vertebral and non-vertebral fracture risk reduction.

Seeman E.

Curr Opin Rheumatol. 2006 Jun;18 Suppl 1:S17-20.

PMID:
16735841
6.

Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.

Adami S.

Bone. 2006 Feb;38(2 Suppl 1):23-7. Epub 2006 Jan 24.

PMID:
16434247
7.
8.

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.

Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ.

J Bone Miner Res. 2006 Apr;21(4):536-42. Epub 2006 Apr 5.

9.

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.

Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ.

Arthritis Rheum. 2008 Jun;58(6):1687-95. doi: 10.1002/art.23461.

10.

Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis.

Liu JM, Wai-Chee Kung A, Pheng CS, Zhu HM, Zhang ZL, Wu YY, Xu L, Meng XW, Huang ML, Chung LP, Hussain NH, Sufian SS, Chen JL.

Bone. 2009 Sep;45(3):460-5. doi: 10.1016/j.bone.2009.05.014. Epub 2009 May 21.

PMID:
19464401
11.

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.

Collette J, Bruyère O, Kaufman JM, Lorenc R, Felsenberg D, Spector TD, Diaz-Curiel M, Boonen S, Reginster JY.

Osteoporos Int. 2010 Feb;21(2):233-41. doi: 10.1007/s00198-009-0940-z. Epub 2009 May 13.

12.

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis.

Roux C, Fechtenbaum J, Kolta S, Isaia G, Andia JB, Devogelaer JP.

Ann Rheum Dis. 2008 Dec;67(12):1736-8. doi: 10.1136/ard.2008.094516. Epub 2008 Aug 19.

13.

Clinical effects of strontium ranelate in women with postmenopausal osteoporosis.

Delmas PD.

Osteoporos Int. 2005 Jan;16 Suppl 1:S16-9. Review.

PMID:
15578158
14.
15.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
16.

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.

Reginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP.

Bone. 2009 Dec;45(6):1059-64. doi: 10.1016/j.bone.2009.08.004. Epub 2009 Aug 11.

PMID:
19679207
17.

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.

Reginster JY, Kaufman JM, Goemaere S, Devogelaer JP, Benhamou CL, Felsenberg D, Diaz-Curiel M, Brandi ML, Badurski J, Wark J, Balogh A, Bruyère O, Roux C.

Osteoporos Int. 2012 Mar;23(3):1115-22. doi: 10.1007/s00198-011-1847-z. Epub 2011 Nov 29.

18.

Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.

Deeks ED, Dhillon S.

Drugs. 2010 Apr 16;70(6):733-59. doi: 10.2165/10481900-000000000-00000. Review.

PMID:
20394457
19.

[Strontium ranelate: a novel concept for the treatment of osteoporosis].

Dimai HP.

Wien Klin Wochenschr. 2005 Nov;117(21-22):728-38. Review. German.

PMID:
16416353
20.
Items per page

Supplemental Content

Write to the Help Desk